Literature DB >> 11448358

Risk factors for postoperative complications in oral cancer and their prognostic implications.

G M de Melo1, K C Ribeiro , L P Kowalski, D Deheinzelin.   

Abstract

BACKGROUND: The surgical treatment of head and neck cancer can be limited by the risk of postoperative complications. Early identification of risk factors based on clinical characteristics may assist therapeutic planning.
OBJECTIVES: To identify risk factors for these complications and to evaluate their prognostic significance.
METHODS: The medical records of 110 patients with oral squamous cell carcinoma admitted from January 1, 1990, to December 31, 1994, who underwent radical surgery were reviewed. Data collected included demographic information, comorbidities, extended clinical severity stage, treatment, complications, and survival. The chi(2) test was used to verify the association between the variables. Survival analysis was performed with the Kaplan-Meier method. Logistic and Cox proportional hazards regression were used to build models with independent predictive factors for the risk of complications and death, respectively.
RESULTS: The overall complication rate was 50%. Dehiscence and infection rates were 20.9% and 22.7%, respectively. The death rate was 3.6%. Forty-seven patients (42.7%) were electively referred to the intensive care unit (ICU). The occurrence of postoperative complications was associated with extended clinical severity stage (P =.02), type of surgery (P =.03), ICU (P =.03), type of reconstruction (P =.02), Functional Severity Index (P =.03), neck dissection (P =.002), and APACHE II (Acute Physiology and Chronic Health Evaluation II) (P =.008). The number of complications was significantly correlated with the length of hospital stay (r = 0.24, P =.01) and with the Functional Severity Index (r = 0.19, P =.04). Five-year overall survival was affected by the type of complications (none, 41.7%; local, 34.1%; and local plus systemic, 0% [P<.001]), ICU (no, 46.3%; yes, 20.7% [P =.001]), and extended clinical severity stage (stage 1, 75.6%; stage 2, 50%; stage 3, 28.6%; and stage 4, 10.2% [P<.001]). In a multivariate analysis bilateral neck dissection (relative risk = 3.57, P =.01) and an APACHE II score greater than 10 (relative risk = 3.86, P =.02) were independent risk factors for complications. The predictive prognostic model consisted of the following: staying in the ICU (hazard ratio = 1.83), local plus systemic complications (hazard ratio = 6.27), and extended clinical severity stage (stage 3, hazard ratio = 3.57; stage 4, hazard ratio = 6.34).
CONCLUSIONS: Bilateral neck dissection and the APACHE II score were identified as risk factors for postoperative complications in oral cancer, which also increase the length of hospital stay. The occurrence of systemic complications, advanced extended clinical severity stage, and staying in an ICU adversely affect the prognosis. Therefore, the prompt recognition of the adverse risk factors for postoperative complications may guide proactive interventions that may improve survival and achieve cost-effectiveness.

Entities:  

Mesh:

Year:  2001        PMID: 11448358

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  36 in total

1.  Profile of oral squamous cell cancer in a tertiary level medical college hospital: a 10 yr study.

Authors:  Raj Govind Sharma; Bhavesh Bang; Hemlata Verma; J M Mehta
Journal:  Indian J Surg Oncol       Date:  2012-07-04

2.  Postpancreatectomy hemorrhage (PPH): predictors and management from a prospective database.

Authors:  B Darnis; R Lebeau; X Chopin-Laly; M Adham
Journal:  Langenbecks Arch Surg       Date:  2013-02-26       Impact factor: 3.445

3.  The application of data mining techniques to oral cancer prognosis.

Authors:  Wan-Ting Tseng; Wei-Fan Chiang; Shyun-Yeu Liu; Jinsheng Roan; Chun-Nan Lin
Journal:  J Med Syst       Date:  2015-03-22       Impact factor: 4.460

4.  Effects of postoperative morbidity on long-term outcome following surgery for colorectal liver metastases.

Authors:  T M Lodewick; M C de Jong; R M van Dam; M H A Bemelmans; U P Neumann; S W M Olde Damink; C H C Dejong
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

5.  Individualized Risk Estimation for Postoperative Complications After Surgery for Oral Cavity Cancer.

Authors:  Mahmoud I Awad; Frank L Palmer; Lei Kou; Changhong Yu; Pablo H Montero; Andrew G Shuman; Ian Ganly; Jatin P Shah; Michael W Kattan; Snehal G Patel
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2015-11       Impact factor: 6.223

6.  Predictors and outcome of early recurrence after resection of hepatic metastases from colorectal cancer.

Authors:  Masaki Kaibori; Yoshinori Iwamoto; Morihiko Ishizaki; Kosuke Matsui; Kazuhiko Yoshioka; Hiroaki Asano; A-Hon Kwon
Journal:  Langenbecks Arch Surg       Date:  2011-10-22       Impact factor: 3.445

7.  A model to predict postoperative complications for otorhinolaryngology and maxillofacial surgery procedures in elderly patients.

Authors:  Luca Giovanni Locatello; Lara Valentina Comini; Alessandra Bettiol; Alfredo Vannacci; Giuseppe Spinelli; Giuditta Mannelli
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-06-03       Impact factor: 2.503

8.  A novel morbidity prediction model for head and neck oncosurgery.

Authors:  Mary Thomas; Nebu Abraham George; Balagopal Prabhakar Gowri; Preethi Sara George; Paul Sebastian
Journal:  Indian J Surg       Date:  2010-11-18       Impact factor: 0.656

9.  Factors Affecting Postoperative Complications After Reconstructive Surgery in Oral Carcinoma Patients: A Prospective Study of 100 Patients.

Authors:  Prateek Vijay Jain; Bhavesh Bang; Kapila Manikantan; Tiash Sinha; Gautam Biswas; Pattatheyil Arun
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-03-19

10.  The impact of different closure materials on pharyngeal wound healing: an experimental animal study.

Authors:  Shih-An Liu; Kwong-Chung Tung; Ching-Chang Cheng; Yung-Tsung Chiu
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-08-28       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.